Biovail, GSK Want Wellbutrin Antitrust Suit Tossed
Biovail Corp. and SmithKline Beecham Corp. have moved to dismiss a consolidated class action complaint against them by indirect purchasers of Wellbutrin XL alleging the drug companies illegally monopolized the market...To view the full article, register now.
Already a subscriber? Click here to view full article